Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

The global specialty active pharmaceutical ingredient market is projected to witness robust growth in the coming decade, reaching an estimated USD 222.4 billion in 2025 and expanding further to ...

Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...

Operating expenses were carefully managed while prioritising investment in growth opportunities, such as Adstiladrin. This resulted in an overall cost reduction of -3% (at AER and CER). Consequently, ...

Continued strong performance in Reproductive Medicine which exceeded sales of €1 billion for the first time Adstiladrin® (nadofaragene ...

In an eagerly anticipated return, Milwaukee Bucks star Giannis Antetokounmpo made his comeback on Tuesday after a brief spell sidelined due to left shoulder tendinopathy. This article explores ...

Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...

DermaClear Serum has quickly become one of the best skin tag removers on the market thanks to its fast results, natural ...

Jammu, signed an agreement on Monday with Kerala-based Pankajakasthuri India Private Limited for the pre-clinical validation ...

There’s a food fight on the horizon, and U.S. farmers stand to lose.

A board-certified family medicine physician explains what a measles vaccine booster is, who should receive it as an adult, ...

OLIPOP CEO Ben Goodwin discusses the past, present, and future of the prebiotic soda brand as it’s reached a $1.85 billion ...